Eckert & Ziegler Radiopharma
Berlin, Germany
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: Eckert & Ziegler Radiopharma
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Berlin, Germany
- Modalities
- Radiopharmaceuticals (alpha, beta, gamma), Radioligand Therapy (RLT), PET diagnostics (F-18, Ga-68), Therapeutic isotopes (Lu-177, Ac-225), Radioactive medical devices, Isotope production & supply, Radiolabeling/conjugation
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Eckert & Ziegler Radiopharma
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesRadiopharmaceuticals (alpha, beta, gamma), Radioligand Therapy (RLT), PET diagnostics (F-18, Ga-68), Therapeutic isotopes (Lu-177, Ac-225), Radioactive medical devices, Isotope production & supply, Radiolabeling/conjugation
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (7 modalities)
Recent News 10 articles
FA considers charging Southampton manager Tonda Eckert with misconduct over spying scandal - the-independent.com
Spygate: Southampton owner Dragan Solak will not sack head coach Tonda Eckert - BBC
'You legend - manager loved it' - Sky Sports
Spygate: Who is Tonda Eckert and can he keep his job? - BBC
Spygate: Southampton head coach Tonda Eckert authorised spying, panel says - BBC
Spygate news: Damning Tonda Eckert verdict as FA investigate and Southampton sack decision looms - The Mirror
Eckert & Ziegler strategy in nuclear medicine, shares on Xetra in a cautious sector - AD HOC NEWS
Woodhaven graduate turns life-changing injury into novel - thenewsherald.com
‘Manager loved it’: Tonda Eckert found to have initiated Southampton’s spying - The Guardian
Brian J. Eckert Obituary (1983 - 2026) - Philadelphia, Pennsylvania - Murphy Ruffenach Brian W. Donnelly Funeral Home
Frequently Asked Questions About Eckert & Ziegler Radiopharma
What is Eckert & Ziegler Radiopharma's CDMO Signal Score?
Eckert & Ziegler Radiopharma has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Eckert & Ziegler Radiopharma for a manufacturing program?
Use the free AI matchmaker to compare Eckert & Ziegler Radiopharma against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.